WEB SEARCH


TOP SELECTION

CONTACT US

info_demofinance@mynasdaq.it

DONATION

All profits of this web site are donated to charity 'the arsenal of peace'. VISIT THE WEBSITE

ADS

Complete financial analysis of SCICLONE PHARMA (SCLN)

Name SCICLONE PHARMA
Year low 3.41
Year High 6.97
Symbol SCLN
Last trade 5.97
Percentage change 0.00
Volume 89,814
Media Volume (3m) 382,081
PE Ratio 10.60
EPS 0.563
Market Cap 339
Media fatt 157
Trend fatt trend fatt graph for SCICLONE PHARMA
Media net income 41
Trend net income trend net income for SCICLONE PHARMA
P / E P / E graph for SCICLONE PHARMA - 14 points 14
EPS EPS graph for SCICLONE PHARMA - 9 points 9
MARKET CAP / TOTAL REVENUE market  cap  /  total  revenue  graph for SCICLONE PHARMA - 4 points 4
TOT REV 1 / TOT REV 2 TOT REV 1 / TOT REV 2 graph for SCICLONE PHARMA - 5 points 5
NET INC 1 / NET INC 2 NET INC 1 / NET INC 2 graph for SCICLONE PHARMA - 2 points 2
MED NET INC / MED TOT REV MED NET INC / MED TOT REV graph for SCICLONE PHARMA - 12 points 12
NET INCOME / MARKET CAP NET  INCOME  /  MARKET  CAP graph for SCICLONE PHARMA - 6 points 6
TOTALREV1/TOTALREV3 totalRev1/totalRev3 graph for SCICLONE PHARMA - 4 points 4
NET INC1/NET INC3 net inc1/net inc3 graph for SCICLONE PHARMA - 3 points 3
TOT REV 2/ TOT REV 3 tot rev 2/ tot rev 3 graph for SCICLONE PHARMA - 5 points 5
NET INC 2 / NET INC 3 net inc 2 / net inc 3 graph for SCICLONE PHARMA - 8 points 8
. . graph for SCICLONE PHARMA - 0 points 0
MARKET CAP / NET TANGIBLE ASSETS MARKET CAP / NET TANGIBLE ASSETS graph for SCICLONE PHARMA - 2 points 2
MARK CAP/TOT STOCK EQ MARK CAP/TOT STOCK EQ graph for SCICLONE PHARMA - 0 points 0
MARKET CAP / TOT CURRENT ASSETS market cap / tot current assets graph for SCICLONE PHARMA - 0 points 0
TOT CURR ASSETS / TOT LIAB TOT CURR ASSETS / TOT LIAB graph for SCICLONE PHARMA - 3 points 3
. . graph for SCICLONE PHARMA - 0 points 0
SELL HOLD BUY SELL           HOLD          BUY graph for SCICLONE PHARMA - 0 points 0
SINTESE 77

GRAPHS

max price logarithm graph for SCICLONE PHARMA based on no conditions max volume linear graph for SCICLONE PHARMA based on no conditions

News

SciClone Reports Financial Results for the First Quarter 2012 (May 09 - reuters) SciClone Pharmaceuticals to Report Financial Results for the First Quarter 2012 on May 9th (May 02 - reuters) SciClone Files S-3 Registration Statement Prospectus Supplement Related to Sigma-Tau Transaction (Apr 30 - reuters) 8 Highly Liquid Healthcare Stocks Undervalued By EPS Trends (Apr 18 - reuters) SciClone Pharmaceuticals Is Dramatically Increasing Profits (Apr 09 - reuters) SciClone Announces Board of Directors and Officer Changes (Apr 06 - reuters) SciClone shares surge to 7-year high on strong outlook (Mar 14 - reuters) SciClone Reports Financial Results for the Fourth Quarter and Year 2011 and Outlook for 2012 (Mar 14 - reuters) Avoid This Biotech Stock (Mar 14 - reuters) 2 $4 Stocks With Rapid Sales Growth That Are Heading Higher (Mar 14 - reuters) SciClone Q4 beats estimates, sees strong 2012 (Mar 14 - reuters) China Biotech Week In Review: GSK Looking To Complete 'Smaller' Acquisition Targets (Mar 14 - reuters) SciClone Pharmaceuticals to Report Financial Results for the Fourth Quarter and Year Ended 2011 and Outlook for 2012 on (Mar 14 - reuters) SciClone Announces Results of Interim Analysis of Phase 2 SCV-07 Oral Mucositis Trial (Mar 14 - reuters) SciClone Pharmaceuticals to Present at RBC Capital Markets' Global Healthcare Conference (Mar 14 - reuters) SciClone Reports Financial Results for the Third Quarter of 2011 (Mar 14 - reuters) SciClone Pharmaceuticals to Present at Three Investor Conferences in November (Mar 14 - reuters) Semi-Annual Changes to the NASDAQ Biotechnology Index (Mar 14 - reuters) SciClone Pharmaceuticals Added to the NASDAQ Biotechnology Index (Mar 14 - reuters) SciClone Pharmaceuticals to Present at BIO CEO & Investor Conference (Mar 14 - reuters) SciClone Pharmaceuticals to Present at Two Investor Conferences in September (Sep 01 - reuters) SciClone Reports Financial Results for the Second Quarter of 2011 (Aug 09 - reuters) SciClone Pharmaceuticals to Report Second Quarter 2011 Financial Results on August 9 (Jul 29 - reuters) » More SCLN.O Market Views (Jul 15 - reuters) What the Market Wants: A Flight to Risk (Jun 28 - reuters) SciClone Presents New Preclinical Data Highlighting Potential Role of SCV-07 in Cancer Treatment at 2011 ASCO Annual (Jun 04 - reuters) SciClone Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference (Jun 02 - reuters) SciClone: Novamed Acquisition Helps, But Questions Remain (May 20 - reuters) SciClone to Present New Preclinical Data on SCV-07 at 2011 ASCO Annual Meeting (May 19 - reuters) SciClone Pharmaceuticals Provides First Quarter Results and Updates 2011 Guidance (May 10 - reuters) » More SCLN.MW Market Views (May 07 - reuters) SciClone Pharmaceuticals to Report First Quarter 2011 Results on May 10 (Apr 29 - reuters) SciClone Acquires NovaMed Pharmaceuticals Further Establishing It as a Leading China-Focused Specialty Pharmaceutical (Apr 19 - reuters) SciClone Pharmaceuticals Provides Fourth Quarter and Year End 2010 Results and 2011 Guidance (Apr 15 - reuters) SciClone Pharmaceuticals to Present at Two Investor Conferences in November (Apr 15 - reuters) » More SCLN.O Market Views (Apr 15 - reuters) 5 Stocks That Might Not Be Trading Under $5 Much Longer (Apr 15 - reuters) The Fool Looks Ahead (Apr 15 - reuters) 10 Pharma Stocks With 100% Buy Ratings (Apr 15 - reuters) 19 High Growth Micro Cap Stocks Under $10 (Apr 15 - reuters) SciClone Pharmaceuticals to Provide Financial Update on April 1 (Apr 15 - reuters) SciClone Reports Preliminary Financial Results for the Fourth Quarter and Year End 2010 (Apr 15 - reuters) SciClone Announces Topline Results From Phase 2b Clinical Trial of SCV-07 for Treatment of Chronic Hepatitis C (Apr 15 - reuters) SciClone Initiates Phase 2b Study of SCV-O7 for Treatment of Oral Mucositis (Apr 15 - reuters) SciClone Pharmaceuticals to Present at BIO CEO & Investor Conference (Apr 15 - reuters) SciClone Pharmaceuticals to Report Fourth Quarter and Year-End Results for 2010 on March 16 (Apr 15 - reuters) SciClone Pharmaceuticals to Present at Two Investor Conferences in March (Apr 15 - reuters) CORRECTED - UPDATE 1-SciClone says internal probe to delay annual report (Mar 17 - reuters) UPDATE 1-SciClone to stop development of HCV drug, shares fall (Jan 28 - reuters) UPDATE 1-SciClone Pharma Q3 EPS beats, raises FY profit view (Jan 28 - reuters)

ADS

MY PORTFOLIO



GAIN vs LOSS


BEST vs WORST


SELECTION DIY

Market Cap
Last Trade
Gain/Loss
Webtech:
P / E
EPS
market cap / total revenue
TOT REV 1 / TOT REV 2
NET INC 1 / NET INC 2
MED NET INC / MED TOT REV
NET INCOME / MARKET CAP
totalRev1/totalRev3
net inc1/net inc3
tot rev 2/ tot rev 3
net inc 2 / net inc 3
.
MARKET CAP / NET TANGIBLE ASSETS
MARK CAP/TOT STOCK EQ
market cap / tot current assets
TOT CURR ASSETS / TOT LIAB
.
SELL HOLD BUY